What a high RDW means on your blood test

Most lines on a CBC (the complete blood count, the standard blood panel) count something. RDW does not. It describes the shape of a distribution: how tightly your red blood cells cluster around their average size. The clinical reference StatPearls defines it as the number that 'quantitatively assesses the degree of variation in red cell size, known as anisocytosis' (StatPearls, 2024). A low-normal RDW means your cells are nearly uniform. A high RDW means old cells and new cells of different sizes are circulating together.

That word anisocytosis matters, because it is the same finding wearing its Greek name. If a blood smear (a drop of blood examined under a microscope) comes back saying 'anisocytosis' or 'anisocytosis noted, mild,' and your CBC shows a high RDW, that is one observation reported twice, once as a word and once as a number. The pages that rank for each term almost never mention the other, which leaves people believing they have two abnormalities. They have one, and it is the mild one.

One more thing worth knowing: you never ordered this test, and neither did your doctor, exactly. RDW 'is a standard parameter of the complete blood count' (Said and colleagues, Pediatric Critical Care Medicine, 2017), calculated automatically by the analyzer on every CBC ever run. It exists mostly as a helper index for interpreting anemia. It was never designed to be read alone, which is precisely how a portal presents it.

Labs report RDW in two formats, and many reports print both. RDW-CV is a percentage: the spread of cell sizes divided by the average cell size, the MCV, times 100 (Danese and colleagues, Journal of Thoracic Disease, 2015). RDW-SD is the spread itself, measured in femtoliters (printed as fL, a volume unit sized for single cells), read off the width of the analyzer's size histogram. Same idea, different units, different printed ranges. The panic version of this trap is a person comparing their RDW-SD of 47 against the 11.5 to 14.5 percent range they found online, and concluding their value is three times the limit.

The two lines can even disagree, and the reason is arithmetic rather than biology. Because RDW-CV divides by the average cell size, a batch of small-but-uniform cells inflates the percentage while the actual spread, the SD, stays normal. A high RDW-CV next to a normal RDW-SD often describes cells that are small and remarkably consistent, not cells that vary. If your report shows both lines and only one is flagged, that mismatch is a known quirk of the math, and it is a good question for your doctor rather than a second problem.

And the ranges themselves are not universal. RDW 'varies depending on the instrument used,' as a Cleveland Clinic Journal of Medicine review puts it plainly (Cleveland Clinic Journal of Medicine, 2019), which is why one lab's report flags a 14.8 and another's does not. The range printed on your own report, from the machine that ran your blood, is the one your value was judged against. A number from a different lab's scale, or from a website, is the wrong ruler.

Here is the honest lay of the land. StatPearls gives a normal adult RDW-CV of roughly 11.5 to 15 percent and adds, in the same sentence, that it 'varies between laboratories.' Cleveland Clinic's patient page prints 12 to 15, with high meaning 15 or more. A review in a pediatric critical-care journal uses 11.5 to 14.5 (Said and colleagues, 2017). These references genuinely disagree at the edges, and none of them outranks the range printed on your own report. The flag on your result means your value sat outside your lab's window, not that it crossed a universal line. The parent guide on reading lab results makes this point about flags in general; RDW is one of the clearest cases of it.

Now the myth. No RDW level is defined as dangerous by any guideline or clinical reference we could find. Some of the top-ranking pages for this search sort RDW into severity tiers anyway, with values above 18 labeled potentially dangerous; those tiers come from a clinic's marketing page, apparently written to match the search phrase 'what level of RDW is dangerous.' RDW does not work that way: it is a description of size spread, and the seriousness of a value depends entirely on why the sizes are spread and what the rest of the CBC shows. A 16 from early iron deficiency and a 16 during recovery from a bleed are the same number with entirely different stories.

What actually moves clinical attention is distance, direction, and company. A 15.1 against a ceiling of 15, by itself, is barely across the line. A value climbing across several draws, or a high RDW traveling with a falling hemoglobin, is a pattern worth a conversation. The sections below sort out which is which. And one sentence for the readers who landed here from the other direction: a low RDW means your red cells are unusually consistent in size, and no condition is diagnosed or suspected from it.

Find the MCV a few lines up on the same report. It stands for mean corpuscular volume, the average size of your red cells, and reading it together with the RDW is this number's entire clinical job. The pairing scheme dates to a 1983 paper (Bessman and colleagues, American Journal of Clinical Pathology), the combinations point in usefully different directions, and the current version of the table lives in StatPearls (2024).

High RDW with a low MCV is the classic signature of iron deficiency: the marrow, running short of iron, starts shipping smaller cells while the older normal ones are still circulating, and the mix widens the curve. The same pairing distinguishes it from thalassemia trait, an inherited and usually harmless condition where cells are small but consistent, so the RDW tends to stay normal (Wallerstein, Western Journal of Medicine, 1987). Honest caveat: the distinction is a lean, not a verdict. In studies the RDW separates the two correctly in most cases but misses enough that doctors confirm with iron studies and, where relevant, hemoglobin analysis rather than trusting the RDW alone.

High RDW with a high MCV points toward B12 or folate shortage, where the marrow ships oversized cells, and also appears with some marrow conditions. High RDW with a normal MCV is the in-between zone: the formal table's entries there run to rarer blood-cell and marrow conditions, and doctors also read it as where early or mixed shortages sit before they declare a direction. And high RDW with everything else normal, the most common real-world version of this search, is usually handled with a recheck rather than a hunt, because it often turns out to be the earliest edge of an iron or vitamin shortage, or nothing reproducible at all.

That early-warning property is the genuinely useful thing about this line. 'RDW is often elevated early in iron deficiency as new microcytic cells are produced alongside older normocytic cells' (The Blood Project); microcytic means smaller than normal, normocytic means normal-sized, and the mix of the two is what widens the curve. The spread widens before the average shifts and before the hemoglobin falls. Which means the calm reading of an isolated high RDW is not 'something is hidden and wrong.' It is: this line sometimes raises its hand before iron deficiency becomes anemia, and a ferritin test, the blood test that measures your iron stores, answers it.

The causes list, starting with the one doctors find most often. Iron deficiency is the front-runner, which in adults usually traces to diet, blood loss (heavy periods, an ulcer, a polyp), the increased demands of pregnancy, or absorption problems. B12 and folate shortage comes next, more common with age, with certain stomach medications, and after some surgeries. Chronic liver and kidney disease are both associated with a wider curve. None of these is exotic, and the first two are among the most fixable findings in medicine.

Recovery does it too, and this one surprises people. After a bleed or a bout of red-cell destruction, the marrow floods the blood with reticulocytes, brand-new cells that run large, and the mix of new large cells with older ones raises the RDW (Cleveland Clinic Journal of Medicine, 2019). A high RDW in the weeks after surgery, childbirth, or a known bleed is often the repair crew showing up in the numbers. The same logic is expected once iron or B12 treatment starts working: the new, corrected cells differ in size from the old ones, so this number can lag, or even look briefly worse, while things get better.

Two quieter entries round out the list. RDW drifts upward with age and with ordinary background inflammation, which is part of why an older adult's mildly high value with stable hemoglobin often stays mildly high for years without meaning anything new (Oberdier and colleagues, Innovation in Aging, 2023). And occasionally the sample itself is the cause: certain antibodies make red cells clump in a cold tube, scrambling the analyzer's size measurements, which is fixed by warming the sample and running it again. A strange value that vanishes on redraw was often never about your blood at all.

Type this search and the suggestions fill in with cancer, so let us handle it properly. First, the plain statement: no cancer is diagnosed from an RDW, and a high RDW is not how cancer announces itself. Patient references list cancers among the many conditions statistically associated with a high RDW (MedlinePlus, 2024), in the same lists as iron shortage, liver disease, and kidney disease, and the everyday entries on those lists are vastly more common than the frightening ones.

Second, the statistical trap behind the scariest claims. In one study of acute myeloid leukemia, 73 percent of patients had a high RDW at diagnosis (Vucinic and colleagues, Blood Advances, 2021). Read carefully, that kind of finding runs in the wrong direction for a worried reader. People with leukemia often have a high RDW because leukemia disrupts red cell production. It does not follow that people with a high RDW are likely to have leukemia, any more than 'most professional basketball players are tall' means most tall people play professional basketball. Blood cancers are rare; mildly high RDWs are everywhere. And leukemia is almost always loud on a CBC: markedly abnormal white counts, falling platelets, falling hemoglobin, often immature cells flagged on the differential. A lone high RDW with those lines quiet is not that picture.

Third, the mortality studies, because a determined googler will find them. A large study of the general US population (15,852 adults in NHANES III) found that people with higher RDWs had higher death rates over the following years, about 23 percent higher per one-unit step in RDW after adjustment (Perlstein and colleagues, Archives of Internal Medicine, 2009). That is a real finding, and here is its honest frame: it is a population-level association, likely reflecting RDW's role as a broad marker of inflammation, nutrition, and chronic illness. The authors themselves note it is unknown whether the risk is even modifiable, and a 2019 review states flatly that using RDW to assess prognosis 'remains investigational' (Cleveland Clinic Journal of Medicine). No guideline turns your RDW into a risk score, and neither should a search result.

If you are reading this line during cancer treatment, the frame changes and gets calmer: treatment and recovery reshuffle red cell production, so a high RDW mid-treatment is common, and your team reads it against the whole panel rather than as its own signal. The counts they actually gate decisions on are covered in the companion guide on low blood counts during chemo.

A lone high RDW and a high RDW with company are different situations, so here are the common pairings. High RDW with low hemoglobin means anemia is present and the RDW is helping explain it; the standard workup starts with iron studies and ferritin, adds B12 and folate, and uses a reticulocyte count and sometimes a look at the smear to sort production problems from loss (Wallerstein, 1987). High RDW with a low MCV starts the iron conversation directly. High RDW with a high MCV starts the B12 and folate one. In each case the follow-up is a short list of ordinary blood tests, not imaging, not a biopsy.

Then there is the pairing people search for by name: high RDW with low absolute lymphocytes. No ranking page answers it, so here is the honest answer. These are two of the most commonly flagged lines on a CBC, with mostly separate everyday causes, RDW from iron and vitamin status, lymphocytes from recent infections and steroids, so they frequently co-occur by coincidence, the way two common weather events share a week. The closest study, which followed 1,715 hepatitis C patients, found that each of the two markers independently predicted higher long-term mortality within that already-sick group (Damjanovska and colleagues, Pathogens and Immunity, 2021). That is a prognosis finding inside one specific cohort, not a diagnostic pattern, and no reference treats the combination as a recognized syndrome. Each line gets its own ordinary explanation first.

The general rule, the same one that runs through every guide in this series: the feared diagnoses almost never leave the rest of the CBC alone. Reassurance is not a page telling you it is probably fine. It is your own hemoglobin, platelets, and white count sitting in range on the same report.

The likely next moves, in order of how often they happen: nothing but a recheck, because an isolated mild elevation with normal hemoglobin is often watched rather than chased; a ferritin and iron panel, because early iron deficiency is the front-runner; B12 and folate levels if the MCV points that way; and a repeat CBC in a few weeks to see whether the value was a state or a trend. If a cause turns up, it is usually treatable, and the RDW drifts back as the cell population turns over, on the order of months, since red cells live about 120 days. Expect the number to lag the fix.

Which makes this line, like every line in this series, as much about your records as your blood. A 15.9 that has read 15-and-something for six years, through six normal physicals, has already answered the scary version of the question. A 15.9 that was 12.8 last spring is worth the ferritin test even though both values look similar on one page. Same digits, opposite meanings, and only the trend can tell them apart. That is the method from reading your results before your doctor calls: whole panel first, then flags, then today's numbers next to the old ones.

This is the part KeptWell was built for. Upload the lab report and it is read and explained: the flagged line decoded in plain English, the source shown, never a diagnosis. Because your CBCs live in one organized place, the question that settles this line, what has this number been before, has an answer in seconds instead of a hunt through three portals. And if you are watching these numbers for an aging parent or someone mid-treatment, the whole family sees the same report and the same plain-English explanation, which spares each of you a separate late-night search over the same percentage.